About: Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.13 (-3.31%)
CRBP NASDAQ Corbus Pharmaceuticals Holding
Corbus Pharmaceuticals Holding share price
CRBP price activity
Last Price
$6.130
Change (24hr)
-0.21 USD (-3.31%)
Volume
834.72K
Volume (4w avg)
-
Open
$6.59
Day Range
$6.06 - $6.68
Previous Close
$6.34
Last Trade
02 Oct, 8:08 pm GMT+0
Delayed
02 Oct, 8:08 pm GMT+0
CRBP price performance
Delayed
02 Oct, 8:08 pm GMT+0
CRBP Market Signals